Literature DB >> 15474402

Cutaneous vasculitis and glomerulonephritis in a patient taking the anti-TNF alpha agent etanercept for rheumatoid arthritis.

Christian Hubert Roux, Olivier Brocq, Véronique Albert C Breuil, Liana Euller-Ziegler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15474402     DOI： 10.1016/j.jbspin.2004.05.008

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN： 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  5 in total

Review 1.  Paradoxical inflammation induced by anti-TNF agents in patients with IBD.

Authors:  Isabelle Cleynen; Séverine Vermeire
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

2.  Tumour necrosis factor alpha blockade and the risk of vasculitis.

Authors:  M De Bandt; B Saint-Marcoux
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

3.  Anaphylactic reaction to anakinra in a rheumatoid arthritis patient intolerant to multiple nonbiologic and biologic disease-modifying antirheumatic drugs.

Authors:  Ditina Desai; Raphaela Goldbach-Mansky; Joshua D Milner; Ronald L Rabin; Keith Hull; Frank Pucino; Nona Colburn
Journal:  Ann Pharmacother       Date:  2009-05       Impact factor: 3.154

Review 4.  Vasculitis induced by tumor necrosis factor-targeted therapies.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Maria-Jose Cuadrado; Munther A Khamashta
Journal:  Curr Rheumatol Rep       Date:  2008-12       Impact factor: 4.592

Review 5.  Chimeric fusion proteins used for therapy: indications, mechanisms, and safety.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2015-05       Impact factor: 5.228
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.